Endovascular Thrombectomy Alone Versus Intravenous Thrombolysis Plus Thrombectomy on Acute Basila… (NCT05827042) | Clinical Trial Compass
RecruitingPhase 3
Endovascular Thrombectomy Alone Versus Intravenous Thrombolysis Plus Thrombectomy on Acute Basilar Artery Occlusion
China338 participantsStarted 2023-05-09
Plain-language summary
To assess the effect of endovascular thrombectomy alone compared to intravenous thrombolysis plus endovascular thrombectomy in acute basilar artery occlusion patients within 4.5 hours from onset on efficacy and safety outcomes.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Patients presenting with posterior circulation ischemic stroke symptoms due to basilar artery occlusion or vertebral artery occlusions that prevent antegrade flow into the basilar artery;
✓. Time from stroke onset to randomization within 4.5 hours of estimated time of basilar artery occlusion;
✓. Patient's age ≥ 18 years;
✓. Presence of basilar artery or vertebral artery occlusion, confirmed by CT Angiography (CTA), MR Angiography (MRA) or Digital Subtraction Angiography (DSA). In case of vertebral artery occlusion, the occlusion must completely prevent antegrade flow into the basilar artery;
✓. Patients presenting with acute ischemic stroke eligible to receive both endovascular thrombectomy and intravenous thrombolysis using standard criteria;
✓. Baseline National Institutes of Health Stroke Scale (NIHSS) score ≥ 10;
✓. The patient or patient's legal representative signs the informed consent form.
Exclusion criteria
✕. CT or MR evidence of intracerebral hemorrhage (the presence of \< 10 microbleeds is allowed);